Lv2
110 积分 2024-08-08 加入
The Novel Nonsteroidal and Selective Mineralocorticoid Receptor Antagonist Finerenone Differentiates from SGLT2 Inhibitor Empagliflozin by Anti-Fibrotic Effects in a Progressive Mouse Kidney Fibrosis Model
6天前
已关闭
Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
11天前
已完结
Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models
1个月前
已完结
HEC95468, a novel soluble guanylate cyclase stimulator, shows protection in the Dahl model of cardiorenal disorder
1个月前
已完结
Quantitative aspects of nitric oxide production in the heart
1个月前
已完结
Nitrite-Nitric Oxide Signaling and Cardioprotection
1个月前
已完结
Cardiorenal Syndrome in Acute Kidney Injury
2个月前
已完结
Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment
2个月前
已完结
皖公网安备34019202002308
